Phenomorphan
|  | |
| Clinical data | |
|---|---|
| Other names | (-)-3-hydroxy- N- (2-phenylethyl) morphinan | 
| ATC code | 
 | 
| Legal status | |
| Legal status | 
 | 
| Identifiers | |
| IUPAC name 
 | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.006.732  | 
| Chemical and physical data | |
| Formula | C24H29NO | 
| Molar mass | 347.502 g·mol−1 | 
| 3D model (JSmol) | |
| SMILES 
 | |
| InChI 
 | |
| (verify) | |
Phenomorphan[1] is an opioid analgesic. It is not currently used in medicine, but has similar side-effects to other opiates, which include itching, nausea and respiratory depression.
Phenomorphan is a highly potent drug due to the N-phenethyl group, which boosts affinity to the μ-opioid receptor, and so phenomorphan is around 10x more potent than levorphanol, which is itself 6-8x the potency of morphine. Other analogues where the N-(2-phenylethyl) group has been replaced by other aromatic rings.[2] are even more potent, with the N-(2-(2-furyl)ethyl) and the N-(2-(2-thienyl)ethyl) analogues being 60x and 45x stronger than levorphanol, respectively.[3]
See also
References
- ↑ US patent 2885401, Grussner A, Hellerbach J, Schnider O, "Process for making morphinan derivatives and products available thereby", published 1956-03-22, issued 1959-05-05
- ↑ US patent 2970147, Andre Grussner, Joseph Hellerbach, Otto Schnider, "3-hydroxy-N-(heterocyclic-ethyl)-morphinans", published 1958-11-26, issued 1961-01-31
- ↑ Hellerbach J, Schnider O, Besendorf H, Pellmont B (1966). Synthetic Analgesics: Part IIA. Morphinans. International series of monographs on organic chemistry. Pergamon Press.
    This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
